CLEAR VISION, TOGETHER
Dr Theodora Georgouli is an ophthalmic surgeon, who has trained and worked in the National Health System (NHS) in the United Kingdom (UK) for 20 years. Dr Georgouli has completed two post-graduate degrees in the UK, on High-resolution imaging in inflammatory eye disease and on the delivery of post-graduate medical education in the medical workplace at the University of Leeds and Edge Hill University respectively.
Dr Georgouli has been in the frontline Ophthalmology Services throughout her career in the UK dealing with both acute and chronic eye conditions from minor eye infections to trauma management and rare ocular presentations. For the last 15 years she has also been involved in specialist care for glaucoma, diabetes, macular degeneration and oculoplastic conditions and has extensive experience in advanced ophthalmic imaging techniques including OCT (optical coherence tomography) and OCT angiography and high resolution MRI (magnetic resonance imaging).
Dr Georgouli has a keen interest in medical education and has held various roles in relation to teaching, training and supervision in ophthalmology. She is also a keen researcher with 24 research publications, participation in major international Ophthalmology studies and has had several presentations on international Ophthalmological meetings, including a prize from the British Trauma Society in 2006.
Dr Georgouli was the winner of Making a Difference Award at Harrogate NHS Foundation Trust in June 2023 for upholding high standards of practice and delivering expert care to her patients.
■ Winner of the “Making a difference Award”, Harrogate NHS Foundation Trust, UK, nominated by colleagues and patients for upholding high standards of practice and delivering expert care to patients, June 2023.
■ Highly commended for making a difference from Chief Executive and Chair of Harrogate NHS Foundation Trust, UK, for the incredible contribution, continued hard work and commitment in providing high quality healthcare, July 2022.
Dr Georgouli has completed two post-graduate degrees in the United Kingdom.
■ Master by Research (MSc), University of Leeds, United Kingdom.
Thesis title: High Resolution Magnetic Resonance Imaging in Inflammatory Eye Disease.
■ Postgraduate Certificate in Workplace-based Postgraduate Medical Education, Edge Hill University, United Kingdom.
With special interest in Teaching and Learning methods, Supporting the post-graduate learner and Supervision, and Professionalism in the medical workplace.
Dr Georgouli has also taught the undergraduate curriculum in Ophthalmology for 5 consecutive years at the University of Leeds and has contributed to the Yorkshire regional Ophthalmology teaching in the United Kingdom.
Over the years Dr Georgouli has 24 research publications, has been involved in mesenchymal stem cell research at the University of Leeds and has been sub-investigator in major international Ophthalmology studies, such as INJECT, SAFARI, LEAVO, CONSTANCE, EDNA, AQUA and FOCUS and has several original presentations on international Ophthalmological meetings, including a prize from the British Trauma Society in 2006.
■ Georgouli T & Walters G. Safety of SubTenon’s anesthesia in cataract surgery. The Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting, Hawai, USA, 2018.
■ Georgouli T, Mackenzie S, Walters G. Diabetic macular oedema treated with ranibizumab and aflibercept: real-life outcomes in a United Kingdom National Health Service setting. Euretina, 17th Congress, Barcelona, Spain, 06/09/2017-10/09/2017.
■ Georgouli T, Burton T, Mackenzie S, Walters G. Intravitreal aflibercept in treatment of naïve neovascular age-related macular degeneration: a prospective single centre cohort study. Euretina, Nice, France, 2015.
■ Tzamos G, Steel D, Airody A, Gale R, Georgouli T, Walters G, Madanat Z, Mookhtiar M, Ramkissoon Y, McKibbin M. Intravitreal ocriplasmin for symptomatic vitreo-macular traction (VMT) – the Yorkshire Retina Society experience. RCOphth Annual Meeting, Liverpool, UK, 2015.
■ Georgouli T, Burton D, Mackenzie S, Walters G. Converting resistant neovascular age-related macular degeneration to aflibercept. Euretina London, UK, 2014.
■ Georgouli T, Ramanathan A, Walters G. The effect of bevacizumab on chronic centrally affecting diabetic macular oedema: visual outcomes with analysis of OCT central subfield thickness and foveal thickness. Euretina, Hamburg, Germany, 2013.
■ Georgouli T, Pountos N, Nelson M, Chang BYP, Saldana M, James T, McGonagle D. Can high resolution MRI score thyroid eye disease activity and severity? A double-blinded prospective study. British Oculoplastic Surgery Society Annual Congress, UK, 2007.
■ Georgouli T, Nelson M, Chang BYP, McGonagle D, James T. Fatty changes in extraocular muscles and orbital tissues in Graves’ ophthalmopathy: Myth or reality? British Oculoplastic Surgery Society Annual Congress, UK, 2007.
■ Georgouli T, Chang B‚ Nelson M, Tanner S, Shelley D, Saldana M, James T, McGonagle D. Use of High-Resolution Microscopy Coil MRI for Depicting Orbital Anatomy. British Oculoplastic Surgery Society (BOPSS) and European Society of Ophthalmic Plastic and Reconstructive Surgery Annual Congress, London, UK, 2006.
■ Georgouli T, Pountos I, Chang BYP, Giannoudis PV. Orbital injuries in trauma patients: Prevalence and outcomes. British Trauma Society (BTS) Annual Congress, UK, 2006.
■ James T & Georgouli T. High-Resolution MR-Eye. Oxford Ophthalmological Congress, Oxford, UK, 2006.
■ Pountos I, Georgouli T, Giannoudis PV. Release of Growth Factors after fracture fixation. BORS, Southampton, UK, 2006.
■ Georgouli T, James T, Chang BY, Backhouse O, Nelson M, Tanner S, Shelley D, McGonagle D. High resolution magnetic resonance imaging in inflammatory eye disease. The Royal College of Ophthalmologists Annual Congress, Manchester, UK, 2006.
■ Georgouli T. Neurosarcoidosis: Presentation of Cases. Clinical Neurology and Neurosurgery, Groningen University Hospital, The Netherlands, 2002.
■ Pountos I, Georgouli T, Henshaw K, Howard B, Giannoudis PV. Mesenchymal Stem Cell physiology can be affected by antibiotics: An in vitro study. Cell Mol Biol (Noisy-le-grand). 2014;60(4):1-7.
■ Pountos I, Panteli M, Georgouli T, Giannoudis PV. Neoplasia following use of BMPs: is there an increased risk? Expert Opin Drug Saf. 2014;13(11):1525-34.
■ Pountos I, Georgouli T, Henshaw K, Bird H, Giannoudis PV. Release of growth factors and the effect of age, sex, and severity of injury after long bone fracture. A preliminary report. Acta Orthop. 2013;84(1):65-70.
■ Georgouli T, Pountos I, Chang BY, Giannoudis PV. Prevalence of ocular and orbital injuries in polytrauma patients. Eur J Trauma Emerg Surg. 2011;37(2):135-40.
■ Pountos I, Georgouli T, Henshaw K, Bird H, Jones E, Giannoudis PV.The effect of bone morphogenetic protein-2, bone morphogenetic protein-7, parathyroid hormone, and platelet-derived growth factor on the proliferation and osteogenic differentiation of mesenchymal stem cells derived from osteoporotic bone. J Orthop Trauma. 2010;24(9):552-6.
■ Georgouli T, Chang B, Nelson M, James T, Tanner S, Shelley D, Saldana M, McGonagle D. Re: “Use of high resolution microscopy coil MRI for depicting orbital anatomy,” ORBIT issue 27.2 (page 107-114)-answer to reader comments. Orbit. 2009;28(2-3):208.
■ McGonagle D, Georgouli T. The importance of ‘Mechnikov’s thorn’ for an improved understanding of 21st century medicine and immunology: a view from the eye. Scand J Immunol. 2008;68(2):129-39.
■ Pountos I, Georgouli T, Giannoudis PV. The effect of autologous serum obtained after fracture on the proliferation and osteogenic differentiation of mesenchymal stem cells. Cell Mol Biol (Noisy-le-grand). 2008;26;54(1):33-9.
■ Georgouli T, Chang B, Nelson M, James T, Tanner S, Shelley D, Saldana M, McGonagle D. Use of high-resolution microscopy coil MRI for depicting orbital anatomy. Orbit. 2008;27(2):107-14.
■ Georgouli T, James T, Tanner S, Shelley D, Nelson M, Chang B, Backhouse O, McGonagle D. High-resolution microscopy coil MR-Eye. Eye (Lond). 2008;22(8):994-6.
MISSION-DRIVEN
Dr Georgouli’s focus is to achieve your best eye health possible and your maximum visual potential by applying solid evidence-based practise and by using her knowledge in cutting-edge technological advances in ophthalmology.
1
2
3
1
2
3
PATH TO EYE HEALTH